Alaunos Therapeutics, Inc. (TCRT): Total Assets
$2.97M
As of 2025-12-31
$1.92M
As of 2026-09-30
-64.3%
3-year compound annual growth
-54.1%
5-year compound annual growth
-32.6%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.97M | +7.7% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $2.75M | -66.7% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $8.26M | -87.3% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $64.94M | -31.5% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $94.86M | -35.2% | 2023-03-07, Balance as of period end |
| 2020-12-31 | $146.34M | +34.1% | 2022-03-30, Balance as of period end |
| 2019-12-31 | $109.11M | +14.8% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $95.05M | -10.0% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $105.61M | -0.7% | 2019-03-05, Balance as of period end |
| 2016-12-31 | $106.35M | -30.8% | 2018-03-01, Balance as of period end |
| 2015-12-31 | $153.72M | +239.8% | 2017-02-16, Balance as of period end |
| 2014-12-31 | $45.24M | -37.0% | 2016-02-24, Balance as of period end |
| 2013-12-31 | $71.75M | -14.0% | 2015-02-26, Balance as of period end |
| 2012-12-31 | $83.40M | -22.9% | 2014-03-03, Balance as of period end |
| 2011-12-31 | $108.11M | +75.7% | 2013-03-18, Balance as of period end |
| 2010-12-31 | $61.52M | n/a | 2012-02-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $2.97M | +7.7% |
| Aspire-Lakewood Holdings, Inc. (ASBP) | 2025-12-31 | $1.31M | +786.7% |
| Genelux Corp (GNLX) | 2025-12-31 | $19.03M | -45.2% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $12.00M | +165.1% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $225.9K | -13.7% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $127.6K | -19.4% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $5.56M | -10.3% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $29.72M | +63.0% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $17.41M | -14.2% |
Compare TCRT, ASBP, GNLX, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗